Author | Robert A. Figlin, MD | OncLive

Author | Robert A. Figlin, MD

Articles

Dr. Figlin on Novel Combinations in Kidney Cancer Treatment

March 02, 2020

Video

Robert A. Figlin, MD, discusses novel combinations in the treatment of patients with kidney cancer.

Dr. Figlin on the Evolving Treatment Landscape of Renal Cell Carcinoma

February 15, 2020

Video

Robert A. Figlin, MD, discusses the evolving treatment landscape of renal cell carcinoma (RCC).

Dr. Figlin on Toxicity Profile of Immunotherapy/VEGF TKI Combinations in RCC

May 09, 2019

Video

Robert A. Figlin, MD, Steven Spielberg Family Chair in Hematology Oncology, director, Division of Hematology/Oncology, deputy director, Integrated Oncology Service Line, and professor of Biomedical Sciences, Medicine, at Cedars-Sinai Medical Center, discusses the toxicity profiles of combinations of immune checkpoint inhibitors and VEGF TKIs in renal cell carcinoma (RCC), as well as research being done to validate potential biomarkers in the space.

Dr. Figlin on Promise of Immunotherapy Plus TKI Combinations in RCC

April 22, 2019

Video

Robert A. Figlin, MD, director, Division of Hematology/Oncology, Steven Spielberg Professor of Biomedical Sciences and Medicine, Cedars-Sinai Medical Center, discusses the promise of immunotherapy plus TKI combinations in the treatment of patients with renal cell carcinoma.

x